Abstract

Kaposi’s sarcoma (KS) is an angioproliferative disease, with a viral etiology and a multifactorial pathogenesis that depends on an immune dysfunction. It is divided into four types according to the aetiology. There was no randomized controlled trials due to very rare disease. Thus clinical guidelines has not been established properly. This review summarized epidemiology, risk factor, and recent treatment strategies in Kaposi sarcoma patients.